RSV Vaccine and mAb Snapshot
This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various such approaches being worked on worldwide.
» Download file (English)
74 KB PDF (Located at www.path.org)
Diseases/vaccines: Respiratory syncytial virus (RSV)